The Spencer Group Podcast

uMotif's CEO, Bruce Hellman, and Head of Global Business Development, Jonathan Stone, chat with Julian Minett of The Spencer Group about the implications of Covid-19 on the biopharmaceutical and pharmatech industries.

Listen to this 13 minute podcast to hear their point of views on the short and long term impacts of Covid-19 and how this pandemic is accelerating the digitisation of research.